ERIC GODDARD: Open Payments
NPI 1053824763 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 69 payments from 21 companies in 2025. Trend: 2023 $947 · 2024 $1,116 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $247 |
| GlaxoSmithKline, LLC. | 12 | $162 |
| Baxter Healthcare | 4 | $156 |
| GENZYME CORPORATION | 11 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| JAZZ PHARMACEUTICALS INC. | 2 | $53 |
| United Therapeutics Corporation | 2 | $37 |
| Viatris Specialty LLC | 2 | $33 |
Products named: DUPIXENT, Hillrom - Vest System Model 105 Home Care, TEZSPIRE, NUCALA, OFEV, GLASSIA, FASENRA, XYWAV.
Industry payments across IN — which companies pay providers there.
